Visit the Kratom Roundtable
2nd CRE Letter to the DEA (September 12, 2016)
1sr CRE Letter to the DEA (September 8, 2016)
CRE has submitted a Request for Information to DEA regarding its listing of kratom as a Schedule I narcotic. The information so requested is the DEA letter to HHS as mentioned in the Federal Register which announced the aforementioned listing, which states:
The Administrator [DEA} transmitted notice of his intent to place mitragynine and 7-hydroxymitragynine in schedule I on a temporary basis to the Assistant Secretary[HHS] by letter dated May 6, 2016.
